Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism
出版年份 2012 全文链接
标题
Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 37, Issue 1, Pages 74-80
出版商
Wiley
发表日期
2012-11-05
DOI
10.1111/apt.12113
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naïve patients infected with HCV genotype 1
- (2012) Lawrence Serfaty et al. GUT
- Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1
- (2012) Eiichi Ogawa et al. JOURNAL OF HEPATOLOGY
- Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C
- (2012) Albert Friedrich Stättermayer et al. JOURNAL OF HEPATOLOGY
- Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response
- (2012) P. J. Clark et al. JOURNAL OF VIRAL HEPATITIS
- The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
- (2012) Jee-Fu Huang et al. LIVER INTERNATIONAL
- IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
- (2011) G. Fattovich et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: insulin resistance and sustained virological response in hepatitis C
- (2011) M. Eslam et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis
- (2011) Pierre Deltenre et al. JOURNAL OF HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Variation of the IL-28B Promoter Affecting Gene Expression
- (2011) Masaya Sugiyama et al. PLoS One
- Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C
- (2010) Albert Friedrich Stättermayer et al. Clinical Gastroenterology and Hepatology
- Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin
- (2010) Jeanette J. McCarthy et al. GASTROENTEROLOGY
- Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
- (2010) Stephen A. Harrison et al. HEPATOLOGY
- Associations between serum lipids and hepatitis C antiviral treatment efficacy
- (2010) Darmendra Ramcharran et al. HEPATOLOGY
- Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes
- (2010) Marco Antonio Montes-Cano et al. HEPATOLOGY
- 1180 A CHROMOSOME 19 SNP (RS12979860) PREDICTS OUTCOME (EVR/SVR) IN HCV PATIENTS TREATED WITH INTERFERON, INDEPENDENT OF PEGYLATION OR RIBAVIRIN
- (2010) T. Asselah et al. JOURNAL OF HEPATOLOGY
- Insulin resistance and sustained virological response in hepatitis C: from bench to bedside
- (2010) Manuel Romero-Gómez LIVER INTERNATIONAL
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now